Video Archives

Diversity in Academic Urology: Where We Stand and Next Steps

Posted by O. Lenaine Westney, MD | Aug 2024

O. Lenaine Westney, MD, analyzes demographic data within academic urology, noting the underrepresentation of certain groups, particularly women and minorities, in faculty and leadership positions. She emphasizes the importance of diversity for fostering innovation, improving patient care, and enriching the educational environment.

Dr. Westney highlights successful initiatives and programs that have been implemented to promote diversity within the field. She discusses the impact of targeted recruitment efforts, diversity training, and mentorship programs designed to support underrepresented groups.
The presentation also addresses the role of institutional policies and leadership commitment in driving change. Dr. Westney advocates for the establishment of clear diversity goals, accountability measures, and dedicated resources to support diversity and inclusion efforts. She underscores the importance of creating a supportive and inclusive culture that values diverse perspectives and experiences.

UPJO Management: Cut, Construct, or Check

Posted by Benjamin K. Canales, MD, MPH | Aug 2024

Benjamin K. Canales, MD, MPH, discusses the pathophysiology and clinical presentation of UPJO, emphasizing its impact on renal function and patient quality of life. He outlines the diagnostic approach, including imaging techniques such as ultrasound, CT, and diuretic renography, which are essential for assessing the obstruction and guiding treatment decisions.

The presentation delves into the three primary management strategies for UPJO: surgical intervention, reconstructive techniques, and conservative monitoring. Dr. Canales provides a detailed analysis of each approach and discusses the indications, success rates, and potential complications of open, laparoscopic, and robotic-assisted pyeloplasty, offering insights into selecting the most appropriate surgical technique based on patient-specific factors.

Dr. Canales reviews the evidence supporting reconstructive techniques, including endopyelotomy and balloon dilation, as minimally invasive alternatives, highlighting their benefits and limitations. Conservative management and active surveillance are presented as viable options for patients with mild or asymptomatic UPJO.

Imaging for High-Risk Prostate Cancer: The Guidelines and Beyond

Posted by Jay D. Raman, MD | Aug 2024

Jay D. Raman, MD, addresses imaging in managing high-risk prostate cancer while providing a comprehensive overview of current guidelines and advancements beyond established protocols.

He details the standard imaging modalities recommended for high-risk prostate cancer, including multiparametric MRI, CT scans, and bone scans. He emphasizes the importance of accurate staging and risk stratification, highlighting how these imaging techniques contribute to treatment planning and prognosis.

Dr. Raman explores emerging imaging technologies that improve the detection and management of high-risk prostate cancer. He reviews the latest advancements in PET imaging, including the use of PSMA-PET, which offers superior sensitivity and specificity in detecting metastatic disease.

Controversies in Percutaneous Nephrolithotomy

Posted by Manoj J. Monga, MD, FACS | Aug 2024

Manoj J. Monga, MD, FACS examines the indications for PCNL, emphasizing the criteria that influence the decision to opt for this invasive treatment. He highlights differing opinions on patient selection and the importance of individualized treatment plans.

Dr. Monga focuses on the technical aspects of PCNL and various approaches and techniques. He reviews the debate over the optimal access points, upper pole versus lower pole entry, and the risks and benefits of miniaturized versus standard tracts. He analyzes outcomes related to stone clearance rates, complications, and recovery times. Dr. Monga further explores the controversies in postoperative management, particularly the use of nephrostomy tubes versus tubeless procedures.

Emerging technologies and innovations in PCNL are also a key part of this presentation. Advancements in imaging techniques, new instruments, and their potential to enhance the safety and effectiveness of the procedure are examined, as well as the need for ongoing research.

Infections Following Prostate Needle Biopsy – An Evidence-Based Approach to Tackling A Common Problem

Posted by Jay D. Raman, MD | Aug 2024

Jay D. Raman, MD addresses infections following prostate needle biopsy, presenting an evidence-based approach to managing this common problem. He notes the prevalence of infections following prostate needle biopsy in recent years, attributing this increase to antibiotic resistance and the inherent risks associated with transrectal biopsy procedures.

At the core of his presentation, Dr. Raman reviews current evidence and guidelines for preventing infections post-biopsy. He examines the role of prophylactic antibiotics and emphasizes the importance of tailoring antibiotic prophylaxis to individual patient risk profiles, including prior infection history, local resistance patterns, and patient comorbidities.

Dr. Raman also explores alternative biopsy techniques aimed at reducing infection rates. A shift towards transperineal biopsy approaches has demonstrated lower infection risks compared to traditional transrectal methods. The presentation includes an analysis of the benefits and limitations of these techniques, supported by recent clinical data.